Glucagon is used for the treatment of hypoglycemia, and glucagon receptor antagonists are under development for the treatment of type 2 diabetes. Moreover, glucagon-like peptide (GLP)-1 and GLP-2 receptor agonists appear to be promising therapies for the treatment of type 2 diabetes and intestinal disorders, respectively. This review discusses the physiological, pharmacological, and therapeutic actions of the proglucagon-derived peptides, with an emphasis on clinical relevance of the peptides for the treatment of human disease.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1152/physiol.00030.2005 | DOI Listing |
Publication Analysis
Top Keywords
proglucagon-derived peptides
8
treatment type
8
type diabetes
8
peptides mechanisms
4
mechanisms action
4
action therapeutic
4
therapeutic potential
4
potential glucagon
4
treatment
4
glucagon treatment
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!